Managing Change In Clinical Trials

By Cal Collins

In clinical research, change can take many forms. From study design to updated regulatory compliance guidelines, new technology releases, and more, it’s important that teams are ready to adapt at a moment’s notice.

A survey of 194 global drug discovery companies conducted by the Tufts Center for the Study of Drug Development (CSDD) found that mid-study updates delay trials by about a month. Smaller companies say the delays run an average of 25 days and larger companies take 35 to 40 days to resume a clinical trial after a planned or unplanned mid-study update. “Companies report an average of four such disruptions per clinical trial.”

Access the full article to explore effective strategies for managing change in clinical trials.